Respiratory Acidosis: Low Arterial Blood pH with Increased Arterial pCO2 and Arterial H2CO3- Increased
Neuromuscular disorders that decrease breathing, as produced by brain stem injury, myasthenia gravis, and poliomyelitis
If sufficiently severe, multiple non-neuromuscular causes of impaired ventilation, perfusion, or gas diffusion produced by embolism, infection, selected cancers, asthma, bronchitis, and emphysema.
Suggested Additional Lab Testing
Serial blood gases to assess arterial pH, arterial pco2 and arterial h2co3 are important to determine the severity and progression of disorders producing respiratory acidosis.
Any neuromuscular disorder or non-neuromuscular disorder leading to respiratory acidosis must be specifically identified from clinical signs and symptoms and other diagnostic tests.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Romosozumab: Effective in Men With Osteoporosis
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Testosterone Prescribing Trends in the United States Between 2002 and 2016
- The Future of Food and Drug Regulation: Trump Administration Proposes Reorganization of FDA, USDA
- Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral Neuropathy
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Subclinical Hypothyroidism: Controversies in Testing and Treatment